Get started
Author

Ahmet BASGOZE

Observed names: Ahmet Başgöze, Başgöze, Ahmet
ORCID: 0000-0002-6992-5461
Observed ORCID: 0000-0002-6992-5461
OpenAlex ID: A5130763000
Prolonged multimodal disease control with trifluridine/tipiracil plus bevacizumab in KRAS-mutant metastatic rectal cancer: a case report
2026 · Onur Alkan, Ahmet Başgöze, et al. · Anti-Cancer Drugs · 1
Pharmacovigilance signals of androgen receptor pathway inhibitors in non-geriatric men with prostate cancer: A FAERS disproportionality analysis.
2026 · Onur Alkan, Ismail Nazlı, et al. · Journal of Clinical Oncology · 1
PDF
Comment on the article [Expression of miR-101-3p and its target ADAM15 gene in colorectal cancer patients]
2026 · Onur Alkan, İsmail Nazlı, et al. · Çukurova medical journal (Online)/Çukurova medical journal
PDF
Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting
2026 · Onur Alkan, İsmail Nazlı, et al. · Cancers
Integrated Prognostic Stratification After Perioperative FLOT in Gastric and Gastroesophageal Junction Adenocarcinoma: A Multicenter Real-World Study
2026 · Seda Jeral Evinç, Zeliha Birsin, et al. · Journal of Clinical Medicine
A Scalable Real-Time Index Management System for Stock Exchange Operations: Architecture and System Model of BEYS
2026 · Altun, Murat Can, Başgöze, Ahmet, et al. · DergiPark (Istanbul University)
PDF
Comment on “PARP-1 rs1136410 Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis of Cancer-Type and Ethnic-Specific Associations”
2026 · Onur ALKAN, Ismail NAZLI, et al. · Medeniyet Medical Journal
PDF
Works count: 7
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type